J&J Hit With $8 Billion Jury Award Over Antipsychotic Drug
A Philadelphia jury ordered Johnson & Johnson to pay $8 billion in damages to a man who said his use of J&J’s antipsychotic Risperdal caused enlarged breasts.
Continue Reading
A Philadelphia jury ordered Johnson & Johnson to pay $8 billion in damages to a man who said his use of J&J’s antipsychotic Risperdal caused enlarged breasts.
Continue Reading
Join the Discussion